Catalog Recovery & Repair Thymosin Alpha-1
Research Compound

Thymosin Alpha-1

Immune modulation & T-cell differentiation

Current Batch SPC-TA1-2409-A
Lot Date September 20, 2024
Purity 99.1%

Where This Comes From

Full traceability from synthesis to your vial. No blind sourcing.

Step 1

cGMP Synthesis

[cGMP Manufacturer — to be disclosed]

cGMP Facility
Step 2

Independent Testing

Analytika ISO Labs Inc. (ISO 17025 Accredited)

ISO 17025 Lab
Step 3

Batch Released

Tested October 5, 2024 — all parameters pass.

COA Published

What's in the Vial

Compound Thymalfasin (Tα1) — 28-residue peptide
Concentration / Fill 1.6 mg lyophilized powder per vial
Sizes Available 1mg / 2mg / 5mg vial
Reconstitution Reconstitute with 1 mL bacteriostatic water
Reconstitution Protocol

Add bacteriostatic water slowly. Gently swirl to dissolve — do not vortex or shake. Refrigerate at 2–8 °C after reconstitution; use within 14 days.

General Protocol Ranges

These are published research ranges — not a prescription. Your physician finalizes your protocol.

Dose Range 1.6 mg per administration
Frequency Twice weekly subcutaneous injection

Standard research protocols use 1.6 mg subcutaneously twice per week. Duration varies by research model from 2 weeks to 6 months depending on the immunological endpoint under study.

Your physician will finalize your specific protocol based on your health profile, goals, and applicable research context.
Physician Network Requirement

Why Physician Oversight?

SourcePeptideCo does not dispense research-grade peptides without licensed physician oversight. This isn't a formality — these compounds interact with individual biochemistry in ways that require clinical judgment.

Our process: you submit a consultation intake, a coordinator matches you with a licensed physician in your state within one business day, and the physician designs a protocol appropriate to your research goals and health profile.

No physician sign-off, no order. That's the standard we hold to.

Request Consultation for Thymosin Alpha-1 →

Frequently Asked Questions